🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Radical Prostatectomy

Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy NCT06450106Phase 14 sites📍 Tucson📍 Gainesville📍 Melbourne N. SURGE Therapeutics · Tests: STM-416p Safety and Early Efficacy of Radical Prostatectomy for Newly Diagnosed Very High Risk Locally Advanced and Oligometastatic Prostate Cancer NCT02971358NA1 site📍 Vienna Medical University of Vienna · Tests: Radical prostatectomy High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy NCT06982469n/a1 site📍 Pamplona Clinica Universidad de Navarra, Universidad de Navarra · Tests: Brachytherapy Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial NCT06022822Phase 25 sites📍 Los Angeles📍 Chicago📍 Chicago National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, Placebo Administration, Urolithin A Supplement Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer NCT05753566Phase 22 sites📍 Nanjing📍 Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Unive… · Tests: Rezvilutamide, Androgen deprivation therapy (ADT), SRT Efficacy and Safety of Radical Prostatectomy (RP) With or Without Salvage Radiotherapy Versus RP With Extended Pelvic Lymph Node Dissection for Localized Intermediate- and High-risk Prostate Cancer With a Briganti Nomogram≥7% NCT07115992NA1 site📍 Shanghai Ruijin Hospital · Tests: RARP±SRT, RARP+ePLND Comparing Two Training Methods for Learning Robot-Assisted Radical Prostatectomy NCT07669974NA1 site📍 Melle Orsi Academy · Tests: IMRA-Enhanced Training Pathway, Standard Training Pathway HCQ in Resectable Localized Prostate Cancer NCT06408298EARLY Phase 11 site📍 Lebanon Lionel.D.Lewis, MD · Tests: Hydroxychloroquine Sulfate 400Mg Tab, Placebo FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer NCT06636682Phase 23 sites📍 Chicago📍 Gahanna📍 Myrtle Beach Cellvax Therapeutics Inc · Tests: FK-PC101, Standard of Care (SOC) Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction NCT06968494NA1 site📍 Baltimore Comphya Inc. · Tests: Activation of pro-erectile nerves within the pelvic plexus Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup]) NCT07831824Phase 2, Phase 31 site📍 Grand Rapids Lantheus Medical Imaging · Tests: [68Ga]-LNTH-2401 Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer NCT05328505NA2 sites📍 London📍 Toronto University Health Network, Toronto · Tests: Image-guided Radiotherapy Multimodal Prehabilitation and Rehabilitation for Men Undergoing Robot-Assisted Radical Prostatectomy NCT07576335Phase 23 sites📍 Sydney📍 Sydney📍 Sydney Surgical Outcomes Research Centre (SOuRCe) · Tests: Tadalafil 5 mg, Pelvic Floor Muscle Training (PFMT), Aerobic Exercise Program, Nutritional Recommendations, Psychologic… Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy NCT06056830Phase 334 sites📍 Birmingham📍 Phoenix📍 Little Rock Clarity Pharmaceuticals Ltd · Tests: 64Cu-SAR-bisPSMA Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer NCT06613100Phase 19 sites📍 San Francisco📍 St Louis📍 Columbus Amgen · Tests: Xaluritamig, GnRH Antagonist Neoadjuvant Therapy of Darolutamide Plus ADT for High Risk Prostate Cancer NCT06575257Phase 21 site📍 Xi’an Xijing Hospital · Tests: Darolutamide, Goserelin 3.6 mg A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer NCT06888102EARLY Phase 11 site📍 Los Angeles Edwin Posadas, MD · Tests: Neoadjuvant Epigenetic Therapy Stem Cells for Erectile Dysfunction Post RALP NCT07048314Phase 1, Phase 21 site📍 Houston The Methodist Hospital Research Institute · Tests: Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) at the doctor's office, Allogeneic adipose-derived m… A Study to Evaluate the Performance of Confocal Microscopy to Detect Positive Margins During Radical Prostatectomy NCT07541911NA1 site📍 London University College, London · Tests: LaserSAFE Long-term Better Than Short-term ADT With Salvage RT NCT04242017Phase 2, Phase 33 sites📍 Ghent📍 Ghent📍 Leuven Universitaire Ziekenhuizen KU Leuven · Tests: Triptoreline Comparison of Prostate Cancer-related Quality of Life in Sexually Active Men With Favourable Intermediate-risk Localised Prostate Cancer Treated With Total Prostatectomy or Focal HIFU NCT06945172NA1 site📍 Quint-Fonsegrives GCS Ramsay Santé pour l'Enseignement et la Recherche · Tests: Total prostatectomy, Focal HIFU Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer NCT07500701Phase 31 site📍 Seoul Samsung Medical Center · Tests: Moderate hypofractionated radiotherapy (Moderate-hypoRT), Ultra-hypofractionated radiotherapy (Ultra-hypoRT) EFFICACY OF INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION ON THE POSTOPERATIVE BLOOD LOSS IN PATIENTS UNDERGOING RARP FOR THE TREATMENT OF PROSTATE CANCER NCT06822036NA3 sites📍 Hamburg📍 Gronau📍 Leipzig St. Antonius Hospital Gronau · Tests: Arm A - Application of 5g of ARISTA™ AH Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy NCT00969111NA6 sites📍 Little Rock📍 Jacksonville📍 Warrenville Proton Collaborative Group · Tests: IMRT to 45 Gy; prostate bed proton boost of 21.6 CGE, Proton (prostate bed) to 70.2 CGE, IMRT to 45 Gy; proton boost to… Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial NCT06966778NA1 site📍 Taipei National Taiwan University Hospital · Tests: Oxybutynin chloride extended-release tablets 5mg/tab, 2 tab, PO, qd., Placebo (2 tab), PO, qd. Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy NCT06798558Phase 23 sites📍 Washington D.C.📍 Washington D.C.📍 Hackensack Hackensack Meridian Health · Tests: Lu-17-PSMA-617 Improved Robotic-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer: Bladder Suspension and Preliminary Outcomes NCT06977906NA1 site📍 Fuzhou First Affiliated Hospital of Fujian Medical University · Tests: conventional Robotic-assisted radical prostatectomy group, Improved Robotic-assisted radical prostatectomy group Safety and Efficacy of Two-step Radical Prostatectomy NCT05722392n/a1 site📍 Guangzhou Sun Yat-sen University · Tests: Two-step Radical Prostatectomy Safety Follow-up Study of Cellgram-ED in Post-Radical Prostatectomy Erectile Dysfunction NCT07431008n/a4 sites📍 Seoul📍 Seoul📍 Seoul Pharmicell Co., Ltd. PSMA-Guided Surgery and Tissue-Resident T-Cell Profiling in Node-Positive Prostate Cancer NCT07879820NA1 site📍 Milan Niguarda Hospital · Tests: PSMA-Radioguided Robot-Assisted Radical Prostatectomy With Extended Pelvic Lymph-Node Dissection
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy